Patents by Inventor Roberto Verga

Roberto Verga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210154273
    Abstract: A composition is disclosed for the treatment of infections caused by pathogenic agents, such as bacteria, fungi, or yeasts. In particular, the composition according to the invention comprises a synergistic association of two peptides, namely lactoferricin and lactoferrampin, which has been shown to be significantly active against such pathogenic agents.
    Type: Application
    Filed: July 24, 2018
    Publication date: May 27, 2021
    Applicant: BICT S.R.L.
    Inventors: Silvia Rapacioli, Roberto Verga, Emma Mazzei, Stefano Zucchinali
  • Publication number: 20170304409
    Abstract: Disclosed are compositions containing a lactoferrin hydrolysate, glycerophosphorylinositol or salts thereof and/or verbascoside which are useful for the prevention and/or treatment of dermatological, otological and stomatological inflammations and infections, in particular in the veterinary sphere.
    Type: Application
    Filed: September 21, 2015
    Publication date: October 26, 2017
    Inventors: Luca Candioli Cravero, Natascia Bruni, Enrico Panetto, Emma Mazzei, Silvia Rapacioli, Roberto Verga
  • Patent number: 7399624
    Abstract: Enzymes with cephalosporin C acylase activity obtained by site-directed, random or “site-saturation” mutagenesis of a native sequence optimised for expression in E. coli.
    Type: Grant
    Filed: January 11, 2005
    Date of Patent: July 15, 2008
    Assignee: Antibioticos S.p.A.
    Inventors: Loredano Pollegioni, Mirella Pilone, Gianluca Molla, Eugenio Cucchetti, Roberto Verga, Walter Cabri
  • Publication number: 20050158818
    Abstract: Enzymes with cephalosporin C acylase activity obtained by site-directed, random or “site-saturation” mutagenesis of a native sequence optimised for expression in E. coli.
    Type: Application
    Filed: January 11, 2005
    Publication date: July 21, 2005
    Applicant: ANTIBIOTICOS S.p.A.
    Inventors: Loredano Pollegioni, Mirella Pilone, Gianluca Molla, Eugenio Cucchetti, Roberto Verga, Walter Cabri
  • Patent number: 5424196
    Abstract: Transformation of Cephalosporin C or its derivatives and salts into 7-aminocephalosporanic acid or its derivatives by an enzymatic two stage process with enzymes immobilized on a solid matrix.
    Type: Grant
    Filed: January 3, 1994
    Date of Patent: June 13, 1995
    Assignee: Antibioticos S.p.A.
    Inventors: Stefano Cambiaghi, Sergio Tomaselli, Roberto Verga